Here are five points:
1. Zacks has a $37 price objective on Smith & Nephew’s stock.
2. Smith & Nephew has a one-year low of $30.23 and a one-year high of $37.84.
3. The company’s 50-day moving average is $33.07 and the 200-day moving average is $34.51.
4. Smith & Nephew has a market cap of $13.93 billion.
5. The P/E ratio is 34.18.
More articles on devices:
ConforMIS reports Q4, full year results — 12 things to know
Hip, knee orthopedic surgical implants market to reach $33M by 2022: 3 takeaways
FDA releases new draft guidance for orthopedic device developers — 6 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
